Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1993 Apr;67(4):801-5.
doi: 10.1038/bjc.1993.146.

Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens

R P A'Hern  1 , I E Smith, S R Ebbs
Affiliations
Free PMC article
Clinical Trial

Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens

R P A'Hern et al. Br J Cancer. 1993 Apr.
Free PMC article

Abstract

The value of the inclusion of doxorubicin hydrochloride (dox) in Cooper type regimens in advanced breast cancer was assessed by performing an overview employing summary statistics derived from published papers of randomised clinical trials comparing Cooper type regimens that contain dox with regimens in which dox was replaced by one or more compounds. Trials were selected which published data on survival, time to treatment failure and response rate. This study suggests that dox confers advantages on all of these endpoints and that the size of such benefits needs to be taken into account when deciding whether to use dox.

PubMed Disclaimer

References

    1. J Clin Oncol. 1985 Jul;3(7):932-40 - PubMed
    1. Breast Cancer Res Treat. 1983;3(2):209-20 - PubMed
    1. Lancet. 1991 Nov 2;338(8775):1127-30 - PubMed
    1. Br J Cancer. 1989 Mar;59(3):396-400 - PubMed
    1. J Clin Oncol. 1987 Oct;5(10):1523-33 - PubMed

MeSH terms

Supplementary concepts